Rain Enhancement Technologies Holdco Inc
- Open
- 1.81
- Day high
- 1.84
- Day low
- 1.66
- Prev close
- 1.89
- Volume
- 22K
- Mkt cap
- $15M
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- -1.1
- P/S
- 1474.0
- Yield
- —
- Per share
- —
- ▲Insiders net buying $101K over the last 3 months (3 open-market buys, 0 sales)
- 🏛Institutions accumulating (13F)
Rain Enhancement Technologies Holdco Inc (RAIN) is a Utilities company listed on NASDAQ. The stock is down 48% over the past year. Over the trailing 3 months, insiders filed 3 open-market buys and 0 sales (SEC Form 4).
Rain Enhancement Technologies Holdco Inc (RAIN) financials & analyst ratings
Fundamentals (TTM)
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
RAIN earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 15, 2026 | — | $-0.24 | — | $10500 | — |
| Nov 13, 2025 | — | $-0.29 | — | — | — |
| Aug 14, 2025 | — | $-0.13 | — | — | — |
| May 15, 2025 | — | $-0.20 | — | — | — |
| Mar 13, 2025 | — | $-0.60 | — | — | — |
| Nov 8, 2024 | — | $-0.44 | — | — | — |
| Mar 14, 2024 | $-0.11 | $-0.01 | +93.4% | — | — |
| Nov 9, 2023 | $-0.27 | $-0.19 | +29.6% | — | — |
| Aug 10, 2023 | $-0.49 | $-0.61 | -24.5% | — | — |
| May 11, 2023 | $-0.57 | $-0.56 | +1.8% | — | — |
| Mar 9, 2023 | $-0.61 | $-0.70 | -14.8% | — | — |
| Nov 10, 2022 | $-0.69 | $-0.68 | +1.4% | — | — |
RAIN insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 9, 2026 | Sylvester David Cdirector | Grant | 40,000 | — |
| Jun 9, 2026 | Riley Christopher Michaeldirector | Grant | 50,000 | — |
| Jun 9, 2026 | Truong Oanhofficer: Interim CFO | Grant | 50,000 | — |
| Jun 9, 2026 | DICKERSON LYMAN Bdirector | Grant | 80,000 | — |
| Jun 9, 2026 | Steele Alexandradirector | Grant | 80,000 | — |
| Jun 9, 2026 | Reardon Robertdirector | Grant | 80,000 | — |
| Jun 9, 2026 | You Harry L.director, 10 percent owner: | Grant | 1,612,903 | $4000000.00 |
| Jun 9, 2026 | PEPERZAK MARCUSdirector | Grant | 80,000 | — |
| May 22, 2026 | Seidl Randydirector, officer: Chief Executive Officer | Buy | 4,000 | $2.58 |
| May 22, 2026 | Seidl Randydirector, officer: Chief Executive Officer | Buy | 30,000 | $2.53 |
| May 22, 2026 | Seidl Randydirector, officer: Chief Executive Officer | Buy | 8,514 | $1.73 |
| Sep 17, 2025 | DICKERSON LYMAN Bdirector | Sell | 1,917 | $5.24 |
| Sep 17, 2025 | DICKERSON LYMAN Bdirector | Sell | 4,787 | $5.78 |
| Sep 17, 2025 | DICKERSON LYMAN Bdirector | Sell | 398 | $5.80 |
| Sep 17, 2025 | DICKERSON LYMAN Bdirector | Sell | 215 | $5.55 |
Source: RAIN SEC Form 4 filings, latest Jun 9, 2026. For informational purposes only — not investment advice.
See the full RAIN insider & 13F page →Rain Enhancement Technologies Holdco Inc company profile
Overview
Rain Enhancement Technologies Holdco Inc (NASDAQ:RAIN) is a recently public company that went public on January 2, 2025, operating as a holding company focused on developing and commercializing ionization rainfall generation technology. The company represents a unique intersection of technology and environmental services, targeting industries, governments, and organizations that require additional rainfall for agricultural, industrial, or environmental purposes. Despite being a newly traded entity, the company appears to have undergone significant corporate changes, as evidenced by historical financial data showing it previously operated as Rain Oncology Inc., a clinical-stage oncology company that pivoted away from cancer drug development after failed trials.
Business
Rain Enhancement Technologies operates in the emerging field of weather modification technology, specifically focusing on ionization-based rainfall generation systems. The company's core technology involves using ionization processes to enhance natural precipitation patterns, essentially creating artificial rainfall in targeted areas. Weather modification is a scientific field that involves deliberately manipulating weather patterns to achieve desired outcomes. The most common form is cloud seeding, where particles are introduced into clouds to encourage precipitation. Rain Enhancement Technologies appears to use a more advanced approach through ionization technology, which involves electrically charging particles in the atmosphere to stimulate cloud formation and precipitation. The company's primary offering centers around providing rainfall generation services to various customer segments including agricultural industries that need consistent water supply, governments dealing with drought conditions, and supranational organizations working on climate adaptation projects. This technology could be particularly valuable in arid regions, during drought periods, or for large-scale agricultural operations that require predictable water access. The weather modification industry is relatively niche but growing, driven by increasing concerns about climate change, water scarcity, and the need for more reliable agricultural water sources. Traditional methods like cloud seeding have been used for decades, but ionization technology represents a potentially more precise and effective approach to rainfall generation.
Competitive moat
Rain Enhancement Technologies operates in a highly specialized niche with limited direct competition, but the strength of its competitive moat appears questionable. The company's primary potential advantage lies in its proprietary ionization technology, which may be more effective or precise than traditional cloud seeding methods. If the technology proves superior in terms of reliability, environmental impact, or cost-effectiveness, this could create a meaningful technological moat. However, several factors suggest the moat may be relatively weak. The weather modification industry includes established players using proven cloud seeding techniques, and the company would need to demonstrate clear superiority to displace existing solutions. Regulatory barriers could provide some protection by making it difficult for new entrants to obtain necessary permits, but these same barriers also constrain the company's own expansion opportunities. The most significant competitive threats come from traditional water management solutions including desalination, water recycling, and improved irrigation efficiency, which may offer more predictable and measurable results. Climate technology companies developing alternative approaches to water scarcity could also pose disruption risks. Additionally, the company faces the fundamental challenge that weather modification remains a relatively unproven field at commercial scale, with limited long-term track record of consistent results. Without strong intellectual property protection or proven operational advantages, the company's moat appears narrow and vulnerable to both technological disruption and regulatory changes.
Risks & safety
The margin of safety appears extremely poor, with the company showing significant financial distress indicators across multiple metrics. • Cash burn and solvency risk: The company burned through $1.0 million in Q1 2025 with only $273,125 in cash remaining, creating immediate liquidity concerns. Current liabilities of $7.7 million vastly exceed current assets of $680,523, resulting in a current ratio of just 0.089. • Debt and capital structure: Total liabilities of $8.1 million significantly exceed total assets of $1.3 million, indicating the company is technically insolvent with negative book value. • Valuation metrics: Despite negative fundamentals, the stock trades at concerning premium levels with negative earnings making traditional valuation metrics unreliable. • Revenue generation: The company has reported zero revenue across all recent periods while maintaining substantial operating losses, indicating the business has not achieved commercial viability. • Historical performance: The company appears to be a corporate transformation from a failed oncology company, suggesting previous business model failures and potential execution risks.
Recent development
Based on the available financial data, Rain Enhancement Technologies appears to represent a significant corporate transformation from its previous incarnation as Rain Oncology Inc. The historical earnings call transcripts reveal that the company previously operated as a clinical-stage oncology company focused on developing milademetan, a cancer treatment targeting MDM2-amplified tumors. The most significant strategic pivot occurred following the failure of the company's Phase 3 MANTRA trial for milademetan in dedifferentiated liposarcoma, which did not meet its primary endpoint. This led to the suspension of the MANTRA-2 study, closure of clinical programs, and substantial workforce reductions that resulted in $2.8 million in restructuring charges. Following the oncology program failures, management indicated they were actively reviewing licensing and acquisition opportunities in precision oncology and exploring potential clinical-stage programs. However, the current business description suggests the company ultimately pivoted completely away from oncology toward weather modification technology. This transformation represents a dramatic shift from drug development to environmental technology services, indicating either an acquisition of weather modification assets or a complete business model overhaul. The lack of recent earnings call transcripts suggests the company may still be in early stages of implementing its new rainfall generation strategy, with no reported revenue from the new business model as of the most recent financial statements.
RAIN company profile · for informational purposes only — not investment advice.
Track RAIN with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free